Table 1.
Clinical and biochemical characteristics of the 21 patients with biliary atresia at time of presentation to our hospital
| Variable | Mean±SD | Median | (Range) |
|---|---|---|---|
| Onset of jaundice (days) | 10.36±9.52 | 7.00 | (7-14) |
| Age at referral (days) | 66±29.2 | 65 | (30-159) |
| Age at performance of KPE (days) | 70±13.5 | 73 | (50-94) |
| Onset of liver failure post KPE (months) | 13.50±5.51 | 13.00 | (8-20) |
| Primary LT (without KPE) (months) | 8.7±2.4 | 8.00 | (4-12) |
| LT post KPE (months) | 8.20±3.35 | 8.00 | (6-12) |
| TSB μmol/L) | 178.29±63.34 | 163.00 | (92-353) |
| Direct bilirubin μmol/L) | 149.90±51.76 | 134.00 | (87-279) |
| ALT (IU/L) | 182.57±102.60 | 174.00 | (62-440) |
| AST (IU/L) | 296.43±147.22 | 245.00 | (105-613) |
| ALP (IU/L) | 961.19±435.13 | 920.00 | (381-1951) |
| GGT (IU/L) | 735.43±576.70 | 730.00 | (90-2328) |
| Serum bile acids μmol/L) | 143.16±47.57 | 143.00 | (78-244) |
SD: Standard deviation; KPE: Kasai portoenterostomy; LT: Liver transplant; TSB: Total serum bilirubin; ALT: Alanine aminotransferase; AST: Aspartate transaminase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transferase